Quick Answer
PROCEPT BioRobotics Corp reported Research And Development Expense of $71.28 million for the year ending 2025.
- PROCEPT BioRobotics Corp showed an increase of +14.4% in Research And Development Expense from 2024 to 2025.
- This data is from PROCEPT BioRobotics Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $3.89 million | Q1 2021: $4.52 million | Q2 2021: $4.48 million | Q3 2021: $4.92 million | Q1 2022: $5.01 million | Q2 2022: $6.71 million | Q3 2022: $7.58 million | Q1 2023: $10.74 million | Q2 2023: $11.61 million | Q3 2023: $11.60 million | Q1 2024: $13.08 million | Q2 2024: $17.50 million | Q3 2024: $16.65 million | Q1 2025: $16.40 million | Q2 2025: $17.63 million | Q3 2025: $18.19 million.
- Over the full 6 years of available data (2020 to 2025), PROCEPT BioRobotics Corp's Research And Development Expense has grown by 338.0%.
- Historical annual values: Fiscal year 2025: $71.28 million | Fiscal year 2024: $62.30 million | Fiscal year 2023: $48.45 million | Fiscal year 2022: $28.98 million | Fiscal year 2021: $18.99 million | Fiscal year 2020: $16.28 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: